patent number 6221847
A method and composition for preventing and treating infection from clinically relevant bacterial isolates is disclosed. The composition contains an anti-bacterial agent that inhibits the growth of the bacteria, including members of both gram negative and gram positive isolates. In particular, the anti-bacterial agent comprises a bacteriocin produced by Propionibacterium. For instance, in one embodiment, the bacteriocin is produced by the B1264 strain of Propionibacterium jensenii.
Clemson University (Clemson, SC)
435/42, 435/170, 435/252.1, 435/252.9, 435/253.4, 514/2.4, 514/2.7, 514/2.8, 514/18.6